+ All Categories
Home > Documents > Phuse Paper AD02 QlikView · 2013-09-11 · PhUSE 2013 1 Paper AD02 QlikView Anthony Caudard,...

Phuse Paper AD02 QlikView · 2013-09-11 · PhUSE 2013 1 Paper AD02 QlikView Anthony Caudard,...

Date post: 04-Jul-2020
Category:
Upload: others
View: 6 times
Download: 0 times
Share this document with a friend
10
PhUSE 2013 1 Paper AD02 QlikView Anthony Caudard, Sanofi, France ABSTRACT The purpose of this paper is to share my first experience developing QlikView dashboard. INTRODUCTION Our service DAS, Data Analytics Services, provides support to the Clinical Sciences & Operations Platform (CSOP). I am identified as solution leader in charge to answer user reporting needs related to the conduct of clinical studies. One of the reporting solutions in my portfolio is Clinical Trial Information 3.3 system (CTI), end-of-life Sanofi product, my challenge was to propose to users an innovative solution with a lower cost and without heavy IT investment. After having examined the various solutions available on the market, we chose business intelligence software QlikView. CLINICAL TRIAL INFORMATION 3.3 PURPOSE Clinical Trial Information (CTI) is dash boarding solution, developed by Sanofi, especially design to assist clinical trial teams in managing their trials efficiently and effectively. This dashboard provides reports/metrics related to: - Study key information, Status and Performance - Country/Site Performance within the study - Site Initiation - Subject Recruitment - Investigator Performance - eCRF Data Collection Workload - Discrepancy Workload It can be accessed by Clinical Sciences & Operations (CSO) users: - Clinical Data Managers - Clinical Trial Managers - Clinical Research Associates (CRA) - Project Leaders / Team Leaders - Region Heads / Country Heads / CSU Heads - Clinical Study Directors (CSD) - Quality Control Specialists - Medical Advisors - And also outside CSO platform like GPE, Finance, etc… All data provided by CTI is derived from the sanofi Clinical Data Management System OC ADAMS and the Sanofi Clinical Data Monitoring System IMPACT.
Transcript
Page 1: Phuse Paper AD02 QlikView · 2013-09-11 · PhUSE 2013 1 Paper AD02 QlikView Anthony Caudard, Sanofi, France ABSTRACT The purpose of this paper is to share my first experience developing

PhUSE 2013

1

Paper AD02

QlikView

Anthony Caudard, Sanofi, France

ABSTRACT The purpose of this paper is to share my first experience developing QlikView dashboard.

INTRODUCTION Our service DAS, Data Analytics Services, provides support to the Clinical Sciences & Operations Platform (CSOP). I am identified as solution leader in charge to answer user reporting needs related to the conduct of clinical studies. One of the reporting solutions in my portfolio is Clinical Trial Information 3.3 system (CTI), end-of-life Sanofi product, my challenge was to propose to users an innovative solution with a lower cost and without heavy IT investment. After having examined the various solutions available on the market, we chose business intelligence software QlikView.

CLINICAL TRIAL INFORMATION 3.3

PURPOSE Clinical Trial Information (CTI) is dash boarding solution, developed by Sanofi, especially design to assist clinical trial teams in managing their trials efficiently and effectively. This dashboard provides reports/metrics related to:

- Study key information, Status and Performance - Country/Site Performance within the study - Site Initiation - Subject Recruitment - Investigator Performance - eCRF Data Collection Workload - Discrepancy Workload

It can be accessed by Clinical Sciences & Operations (CSO) users:

- Clinical Data Managers - Clinical Trial Managers - Clinical Research Associates (CRA) - Project Leaders / Team Leaders - Region Heads / Country Heads / CSU Heads - Clinical Study Directors (CSD) - Quality Control Specialists - Medical Advisors - …

And also outside CSO platform like GPE, Finance, etc… All data provided by CTI is derived from the sanofi Clinical Data Management System OC ADAMS and the Sanofi Clinical Data Monitoring System IMPACT.

Page 2: Phuse Paper AD02 QlikView · 2013-09-11 · PhUSE 2013 1 Paper AD02 QlikView Anthony Caudard, Sanofi, France ABSTRACT The purpose of this paper is to share my first experience developing

PhUSE 2013

2

HISTORY 2002 Jun Version 1.0 released

Nov Version 1.1 released

2003 Mar Version 1.2 released Jun Version 1.3 released Dec Version 1.4 released

2004 Aug Version 1.5 released 2005 Oct Version 2.0 released 2006 May Version 2.1 released

Oct Version 2.2 released 2007 Feb Version 2.3 released

Jul Version 3.0 released Oct Version 3.1 released Dec Version 3.2 released

2008 Jun Version 3.3 released From 2009, CTI reports usage remains low while reporting needs for eCRF studies increase and general perception shows a lack of confidence Reasons:

- Data Accuracy \ Inconsistencies Issues - Refresh Cycle Frequency ( original refresh frequency : 2 / day , current refresh frequency 1 refresh per

weekday ) - eCRF Study designs Complexity - Technologies Constraints (Informatica & Java upgrades) - Development Timelines / Resources availability

In 2012, as CTI solution leader, I had the opportunity to launch initiative to build a “CTI” prototype with innovative solution QlikView.

WHAT IS QLIKVIEW? QlikView is a flagged product of QlikTech Company and can be classified in the category of Business Intelligence (BI) tools. Qlikview is used by more than 29,000 organizations in more than 100 countries around the world. QLIKVIEW STRENGTHS: MAKING THE COMPLEX SIMPLE

One of its strengths is that it can consolidate information rapidly from any data source (Oracle, SAP, Salesforce.com, SQL Server, Excel...)

It then provides associative search facilities, which the supplier likens to Google's Instant Search, with the interface highlighting significant relationships in the data.

Thirdly, QlikView provides flexible, intuitive, and powerful data visualizations.

Lastly, results can be printed as reports, saved as Adobe PDFs, sent to Microsoft Excel or copied into other Microsoft Office applications.

QLIKVIEW PLATFORM

The QlikView platform consists of 3 major components – QlikView Server, QlikView Publisher and QlikView Desktop, each playing an important part in designing, developing and implementing almost every QlikView deployment (see Figure 1).

In a typical QlikView deployment, developers focus on:

Page 3: Phuse Paper AD02 QlikView · 2013-09-11 · PhUSE 2013 1 Paper AD02 QlikView Anthony Caudard, Sanofi, France ABSTRACT The purpose of this paper is to share my first experience developing

PhUSE 2013

3

Managing data extracts and data and system security

Creating and maintaining source QlikView files (QVWs and QVDs)

Controlling data refresh and application distribution through QlikView Publisher

Administering QlikView deployments via the QlikView Management Console (part of QVS)

Figure 1 QlikView Architecture Overview

Page 4: Phuse Paper AD02 QlikView · 2013-09-11 · PhUSE 2013 1 Paper AD02 QlikView Anthony Caudard, Sanofi, France ABSTRACT The purpose of this paper is to share my first experience developing

PhUSE 2013

4

CLINICAL TRIAL INFORMATION 4.0 The initiative was launched beginning 2012 using Agile development methodology (1 developer & 4 Subject Experts: 2 TO, 1 PL, 1 Q&CI. ) First release has been deployed in July 2012. Figure 2 CTI Data Model

Page 5: Phuse Paper AD02 QlikView · 2013-09-11 · PhUSE 2013 1 Paper AD02 QlikView Anthony Caudard, Sanofi, France ABSTRACT The purpose of this paper is to share my first experience developing

PhUSE 2013

5

Registered users connect via a portal dedicated to QlikView (see Figure 3). Figure 3 QlikView Access Point

When a user first opens CTI document, data is loaded in memory. Figure 4 shows an image of the application Home page. Here the users can have access to projects/studies depending on their roles/study assignments.

Page 6: Phuse Paper AD02 QlikView · 2013-09-11 · PhUSE 2013 1 Paper AD02 QlikView Anthony Caudard, Sanofi, France ABSTRACT The purpose of this paper is to share my first experience developing

PhUSE 2013

6

Figure 4 CTI Home Page

User explores data via selections. Every object in QlikView – from lists, to graphs, to tables – is clickable. All objects interact so that a selection in one affects the others. Query results are revealed instantly through intuitive color coding; selected values are highlighted green, linked values are highlighted white, and excluded values are highlighted gray (see Figure 5).

Page 7: Phuse Paper AD02 QlikView · 2013-09-11 · PhUSE 2013 1 Paper AD02 QlikView Anthony Caudard, Sanofi, France ABSTRACT The purpose of this paper is to share my first experience developing

PhUSE 2013

7

Figure 5 User Selection in CTI Home Page

Figure 6 Study Overview

Page 8: Phuse Paper AD02 QlikView · 2013-09-11 · PhUSE 2013 1 Paper AD02 QlikView Anthony Caudard, Sanofi, France ABSTRACT The purpose of this paper is to share my first experience developing

PhUSE 2013

8

Figure 7 Study Progress

Figure 8 Discrepancy Workload

Page 9: Phuse Paper AD02 QlikView · 2013-09-11 · PhUSE 2013 1 Paper AD02 QlikView Anthony Caudard, Sanofi, France ABSTRACT The purpose of this paper is to share my first experience developing

PhUSE 2013

9

Figure 9 Printable PDF Report

1 YEAR AFTER….CTI AND QLIKVIEW SUCCESS STORIES - Over 1500 CTI worldwide users - 800 CTI users / Month - High level of customer Satisfaction. Below, 1 User feedback in Sanofi Social Network: “I would like to express a big thank you to TIM and especially Anthony Caudard for the work that has been done for the implementation of CTI 4.0. At first, we felt very skeptic to have CTI 3.3 replaced with a new tool. CTI 3.3 was one of the most liked tools in our CSU….Positive feedback has been received …All users find the information, they need in the tool…Also we have seen most of our requests and wishes for the tool implemented within a very short timeframe. It is the willingness of the solution leader to adapt the tool to the end users which makes the tool appreciated and used in the daily work of as many users as possible. We would love to see something similar for future Tools.” - 4 daily CTI refreshes - Automatic Access management ( no more paper access requests) - 5 Qlikview applications deployed to CSO users. - Qlikview selected as dash boarding solution in ambitious program Sanofi UNIFY

Page 10: Phuse Paper AD02 QlikView · 2013-09-11 · PhUSE 2013 1 Paper AD02 QlikView Anthony Caudard, Sanofi, France ABSTRACT The purpose of this paper is to share my first experience developing

PhUSE 2013

10

CONCLUSION QlikView = Quick + Qlear + Qool In choosing Qlikview to create your application, you ensure: - Faster development and deployment (1-3 Months) - Low TCO (Total Cost of Ownership) - Ease of development - Ease of use for the business users with minimal training - Higher customer satisfaction

RECOMMENDED READING

QlikView Website: http://www.qlikview.com/

View QlikView Apps: http://eu.demo.qlikview.com/

QlikCommunity: http://community.qlikview.com/welcome

CONTACT INFORMATION Your comments and questions are valued and encouraged. Contact the author at:

Author Name: Anthony CAUDARD Company: SANOFI Address: 1, AVENUE PIERRE BROSSOLETTE City / Postcode: 91385 Chilly-Mazarin Work Phone: +33 1 60 49 41 34 Fax: +33 1 60 49 48 25 Email: [email protected]


Recommended